Mineralys Therapeutics Inc (MLYS) USD0.0001
2.77%- This stock can be held in a
Stocks and Shares ISASell:$13.89
Buy:$13.93
Change:
$0.62
(4.25%)
$0.62
(4.25%)Market closed | Prices delayed by at least 15 minutes
Sell:$13.89
Buy:$13.93
Change:$0.62
(4.25%)
$0.62
(4.25%)Market closed | Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 11 July 2024 | Jon CongletonCEO | Sell Option/Award related | 15,746 | $13.34 | $210,075.26 | 911,212 |
| 11 July 2024 | Adam Scott LevyCFO | Sell Option/Award related | 10,757 | $13.14 | $141,394.31 | 247,611 |
| 20 June 2024 | Jon CongletonCEO | Sell Regular sell transaction (market) | 14,940 | $11.73 | $175,237.24 | 926,958 |
| 18 June 2024 | Jon CongletonCEO | Sell Regular sell transaction (market) | 16,607 | $11.99 | $199,073.09 | 941,898 |
| 17 June 2024 | Jon CongletonCEO | Sell Regular sell transaction (market) | 17,766 | $12.25 | $217,711.67 | 958,505 |
| 14 June 2024 | Jon CongletonCEO | Sell Regular sell transaction (market) | 16,229 | $12.52 | $203,162.74 | 976,271 |
| 13 June 2024 | Jon CongletonCEO | Sell Option/Award related | 39,961 | $12.74 | $509,027.21 | 992,500 |
| 12 June 2024 | Jon CongletonCEO | Sell Option/Award related | 16,607 | $12.77 | $212,013.27 | 1,032,461 |
| 11 June 2024 | Adam Scott LevyCFO | Sell Option/Award related | 96,815 | $12.94 | $1,252,718.33 | 255,462 |
| 9 May 2024 | David Malcom RodmanOther Level A | Sell Option/Award related | 100 | $15.00 | $1,500.00 | 66,997 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 12 February 2024 | RA CAPITAL MANAGEMENT LLCInvestment Management Company | Buy Regular purchase transaction | 1,672,508 | $13.50 | $22,578,858.00 | 2,983,755 |
| 12 February 2024 | SAMSARA BIOCAPITAL GP LLCVenture Capital | Buy Regular purchase transaction | 555,555 | $13.50 | $7,499,992.50 | 5,074,916 |
| 12 February 2024 | RA CAPITAL MANAGEMENT LLCInvestment Management Company | Buy Regular purchase transaction | 549,755 | $13.50 | $7,421,142.75 | 549,755 |
| 11 June 2024 | Adam Scott LevyCFO | Sell Option/Award related | 96,815 | $12.94 | $1,252,718.33 | 255,462 |
| 11 August 2023 | David Malcom RodmanOther Level A | Sell Option/Award related | 80,909 | $12.81 | $1,036,444.29 | 0 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.